CQS
NVO

Credential Qtrade Securities’s Novo Nordisk NVO Stock Holding History

Credential Qtrade Securities’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$3.84M Buy
29,887
+543
+2% +$64.6K 0.21% 62
2023
Q4 		$3.04M Sell
29,344
-2,564
-8% -$254K 0.18% 68
2023
Q3 		$2.9M Buy
31,908
+874
+3% +$77K 0.19% 68
2023
Q2 		$2.51M Buy
31,034
+2,626
+9% +$215K 0.16% 75
2023
Q1 		$2.26M Buy
28,408
+66
+0.2% +$4.68K 0.15% 77
2022
Q4 		$1.92M Buy
28,342
+1,110
+4% +$65.1K 0.14% 82
2022
Q3 		$1.36M Buy
27,232
+684
+3% +$36.6K 0.11% 100
2022
Q2 		$1.48M Buy
26,548
+1,594
+6% +$88.5K 0.11% 96
2022
Q1 		$1.39M Buy
24,954
+2,256
+10% +$116K 0.09% 107
2021
Q4 		$1.27M Buy
22,698
+362
+2% +$19.6K 0.09% 110
2021
Q3 		$1.07M Buy
22,336
+4,838
+28% +$234K 0.08% 112
2021
Q2 		$733K Buy
17,498
+416
+2% +$16.1K 0.06% 145
2021
Q1 		$576K Buy
17,082
+136
+0.8% +$4.84K 0.05% 146
2020
Q4 		$592K Sell
16,946
-90
-0.5% -$3.11K 0.06% 129
2020
Q3 		$591K Sell
17,036
-270
-2% -$9K 0.07% 124
2020
Q2 		$567K Buy
17,306
+798
+5% +$25.5K 0.07% 123
2020
Q1 		$497K Buy
+16,508
New +$492K 0.08% 114
2019
Q3 		– Sell
-116
Closed -$2.96K – 296
2019
Q2 		$2.96K Buy
+116
New +$2.87K ﹤0.01% 277
2018
Q4 		– Sell
-18,640
Closed -$439K – 284
2018
Q3 		$439K Buy
+18,640
New +$455K 0.09% 124

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Credential Qtrade Securities's NVO Position: Q1 2024 in Review

Credential Qtrade Securities increased its Novo Nordisk (NVO) stake by 1.9% in Q1 2024, buying an estimated $64.6K and bringing the position to 29,887 shares worth $3.84M. The position accounts for 0.21% of the portfolio, ranked #62.

Credential Qtrade Securities first reported a position in NVO in Q3 2018 and has held it in 19 quarters since. 1,746 funds tracked by Wall St. Rank hold NVO as of Q1 2024.

  • Credential Qtrade Securities held 29,887 shares of Novo Nordisk worth $3.84M as of Q1 2024.
  • Credential Qtrade Securities bought 543 Novo Nordisk shares in Q1 2024, an estimated $64.6K.
  • Novo Nordisk made up 0.21% of Credential Qtrade Securities's portfolio in Q1 2024, its #62 holding.
  • Credential Qtrade Securities first reported a position in Novo Nordisk in Q3 2018 and has held it in 19 quarters since.
  • 1,746 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2024.

Based on Credential Qtrade Securities's 13F filing for Q1 2024, filed 21 Jul 2025.